Transcriptional cross-talk, the second mode of steroid hormone receptor action - PubMed (original) (raw)
Review
Transcriptional cross-talk, the second mode of steroid hormone receptor action
M Göttlicher et al. J Mol Med (Berl). 1998 Jun.
Abstract
Physiological and therapeutic activities of glucocorticoids and other steroid hormones are mediated by the family of steroid hormone receptors. In addition to the classical mode of receptor action which involves binding as a dimer to regulatory sequences in target gene promoters and subsequent activation of transcription, a second mode of action is based predominantly on protein-protein interactions. As the paradigm of this so-called transcriptional cross-talk, the glucocorticoid receptor (GR) and the AP-1 transcription factor interact on target gene promoters which contain only a binding site for either one of the two transcription factors. Most frequently negative interference of both factors with each other's activity has been observed, for example, when AP-1 is composed of c-Fos and c-Jun; however, synergism is also possible under cell-specific conditions and when AP-1 is a homodimer of c-Jun. Since the detection of the GR/AP-1 cross-talk numerous other examples of transcription factor interactions have been described. Many members of the nuclear hormone receptor superfamily, including class II receptors, have been shown to participate in such cross-talk. Moreover, the transcription factor families of NF-kappaB/Rel as well as Stat, Oct, and C/EBP are engaged in cross-talk with steroid receptors. Despite the identification of a multitude of target genes which appear to be regulated by this type of transcription factor interaction, the exact molecular mechanism of the cross-talk has not yet been elucidated. This review discusses the current models to explain the molecular events of transcription factor cross-talk. Concepts are emphasized which suggest that the classical and the cross-talk mode of steroid receptor action can be triggered separately by the choice of specific ligands. A final section summarizes the partially contradictory data which assign a certain type of receptor action to a biological response particularly in the immune system.
Comment in
- Steroid hormone action 1998: novel challenges for drug design.
Cato AC, Stock G, Fuhrmann U. Cato AC, et al. J Mol Med (Berl). 1998 Jun;76(7):459-60. doi: 10.1007/s001090050238. J Mol Med (Berl). 1998. PMID: 9660162 No abstract available.
Similar articles
- Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells.
Refojo D, Liberman AC, Giacomini D, Carbia Nagashima A, Graciarena M, Echenique C, Paez Pereda M, Stalla G, Holsboer F, Arzt E. Refojo D, et al. Ann N Y Acad Sci. 2003 May;992:196-204. doi: 10.1111/j.1749-6632.2003.tb03150.x. Ann N Y Acad Sci. 2003. PMID: 12794059 Review. - How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D, Vanden Berghe W, Dejager L, Libert C, Tavernier J, Beck IM, De Bosscher K. Ratman D, et al. Mol Cell Endocrinol. 2013 Nov 5;380(1-2):41-54. doi: 10.1016/j.mce.2012.12.014. Epub 2012 Dec 23. Mol Cell Endocrinol. 2013. PMID: 23267834 Review. - Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. Caldenhoven E, et al. Mol Endocrinol. 1995 Apr;9(4):401-12. doi: 10.1210/mend.9.4.7659084. Mol Endocrinol. 1995. PMID: 7659084 - Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
Uht RM, Anderson CM, Webb P, Kushner PJ. Uht RM, et al. Endocrinology. 1997 Jul;138(7):2900-8. doi: 10.1210/endo.138.7.5244. Endocrinology. 1997. PMID: 9202234 - Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata H, Spencer TE, Oñate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW. Shibata H, et al. Recent Prog Horm Res. 1997;52:141-64; discussion 164-5. Recent Prog Horm Res. 1997. PMID: 9238851 Review.
Cited by
- Thyroid Hormone Upregulates Cav1.2 Channels in Cardiac Cells via the Downregulation of the Channels' β4 Subunit.
Carrillo ED, Alvarado JA, Hernández A, Lezama I, García MC, Sánchez JA. Carrillo ED, et al. Int J Mol Sci. 2024 Oct 8;25(19):10798. doi: 10.3390/ijms251910798. Int J Mol Sci. 2024. PMID: 39409130 Free PMC article. - The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.
Figueira MI, Carvalho TMA, Macário-Monteiro J, Cardoso HJ, Correia S, Vaz CV, Duarte AP, Socorro S. Figueira MI, et al. Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636. Biomedicines. 2024. PMID: 39200101 Free PMC article. Review. - The impact of estradiol on serotonin, glutamate, and dopamine systems.
Bendis PC, Zimmerman S, Onisiforou A, Zanos P, Georgiou P. Bendis PC, et al. Front Neurosci. 2024 Mar 22;18:1348551. doi: 10.3389/fnins.2024.1348551. eCollection 2024. Front Neurosci. 2024. PMID: 38586193 Free PMC article. Review. - Estrogen dysregulation, intraocular pressure, and glaucoma risk.
Youngblood H, Schoenlein PV, Pasquale LR, Stamer WD, Liu Y. Youngblood H, et al. Exp Eye Res. 2023 Dec;237:109725. doi: 10.1016/j.exer.2023.109725. Epub 2023 Nov 11. Exp Eye Res. 2023. PMID: 37956940 Review. - Changes in Cortisol Secretion and Corticosteroid Receptors in COVID-19 and Non COVID-19 Critically Ill Patients with Sepsis/Septic Shock and Scope for Treatment.
Ilias I, Vassiliou AG, Keskinidou C, Vrettou CS, Orfanos S, Kotanidou A, Dimopoulou I. Ilias I, et al. Biomedicines. 2023 Jun 23;11(7):1801. doi: 10.3390/biomedicines11071801. Biomedicines. 2023. PMID: 37509441 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous